Cognition Therapeutics, Inc. (CGTX)
1.285
+0.18
(+15.77%)
USD |
NASDAQ |
May 20, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Cognition Therapeutics EPS Diluted (Quarterly) : -0.0512 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Verrica Pharmaceuticals, Inc. | -0.4544 |
| Terns Pharmaceuticals, Inc. (DELISTED) | -0.2395 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.57M |
| Total Expenses (Quarterly) | 4.57M |
| Enterprise Value | 68.58M |
| Earnings Yield | -20.05% |
| Normalized Earnings Yield | -20.06 |